Feng Pan
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
-
- RNA modifications and cancer
- Circular RNAs in diseases
- RNA Research and Splicing
- Epigenetics and DNA Methylation
Papers in
-
- Cancer, Hypoxia, and Metabolism 4
- MicroRNA in disease regulation 3
- NF-κB Signaling Pathways 3
-
- RNA modifications and cancer 6
- Cancer-related gene regulation 4
- Epigenetics and DNA Methylation 4
- Co-authors
- Wei Gu (3 shared papers)Houjie Liang (6 shared papers)En-Min Li (11 shared papers)Li‐Yan Xu (10 shared papers)Ganfeng Xie (4 shared papers)Robert H. Singer (1 shared paper)Yang Sun (5 shared papers)Wei Yi (5 shared papers)
- Journals
- Cell Death and Disease (3 papers)Cancer Cell International (2 papers)BioMed Research International (2 papers)Biological and Pharmaceutical Bulletin (1 paper)Genes & Diseases (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Feng Pan
56 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 107
- Cancer Research 280
- Molecular Biology 638
- Immunology and Allergy 44
- Oncology 160
- Toxicology 18
Countries citing papers authored by Feng Pan
This map shows the geographic impact of Feng Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Pan more than expected).
Fields of papers citing papers by Feng Pan
This network shows the impact of papers produced by Feng Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Pan. The network helps show where Feng Pan may publish in the future.
Co-authors
The 25 scholars most cited alongside Feng Pan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 87 | |
| 2 | 2019 | 70 | |
| 3 | 2018 | 68 | |
| 4 | 2010 | 62 | |
| 5 | 2019 | 60 | |
| 6 | 2009 | 59 | |
| 7 | 2014 | 53 | |
| 8 | 2018 | 44 | |
| 9 | 2017 | 43 | |
| 10 | 2011 | 43 | |
| 11 | 2019 | 39 | |
| 12 | The activation of GPER inhibits cells proliferation, invasion and EMT of triple-negative breast cancer via CD151/miR-199a-3p bio-axis. | 2020 | 37 |
| 13 | 2016 | 34 | |
| 14 | 2009 | 33 | |
| 15 | 2016 | 33 | |
| 16 | 2010 | 31 | |
| 17 | 2023 | 28 | |
| 18 | 2019 | 27 | |
| 19 | 2016 | 27 | |
| 20 | 2013 | 25 |
About Feng Pan
Feng Pan is a scholar working on Cancer Research, Molecular Biology, Immunology and Allergy, Immunology and Oncology, having authored 57 papers that have together received 1.3k indexed citations. Recurring topics across this work include RNA modifications and cancer (6 papers), Esophageal Cancer Research and Treatment (6 papers), Cancer, Hypoxia, and Metabolism (4 papers), Cancer-related gene regulation (4 papers), Epigenetics and DNA Methylation (4 papers), Cell Adhesion Molecules Research (4 papers), MicroRNA in disease regulation (3 papers) and NF-κB Signaling Pathways (3 papers). The work is most often cited by research in Cancer Research (280 citations), Molecular Biology (638 citations), Immunology and Allergy (44 citations), Oncology (160 citations) and Toxicology (18 citations). Feng Pan has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Wei Gu, Houjie Liang, En-Min Li, Li‐Yan Xu, Ganfeng Xie, Robert H. Singer, Yang Sun, Wei Yi, Erhe Gao and Yanzhen Tan. Their work appears in journals such as Cell Death and Disease, Cancer Cell International, BioMed Research International, Biological and Pharmaceutical Bulletin and Genes & Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.